このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Eris Lifesciences 配当金
配当金 基準チェック /26
Eris Lifesciences配当を支払う会社であり、現在の利回りは0.72%です。
主要情報
0.7%
配当利回り
0%
配当性向
| 業界平均利回り | 0.8% |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | n/a |
| 一株当たり利益 | ₹28.81 |
| 3年後の配当利回り予想 | 0.8% |
最近の配当金アップデート
Eris Lifesciences Limited (NSE:ERIS) Looks Interesting, And It's About To Pay A Dividend
Aug 08
Should You Buy Eris Lifesciences Limited (NSE:ERIS) For Its Upcoming Dividend?
Aug 08Recent updates
Eris Lifesciences Limited (NSE:ERIS) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?
May 24
Why We're Not Concerned About Eris Lifesciences Limited's (NSE:ERIS) Share Price
May 10An Intrinsic Calculation For Eris Lifesciences Limited (NSE:ERIS) Suggests It's 25% Undervalued
Mar 14Analyst Estimates: Here's What Brokers Think Of Eris Lifesciences Limited (NSE:ERIS) After Its Third-Quarter Report
Feb 15Earnings Tell The Story For Eris Lifesciences Limited (NSE:ERIS)
Dec 28Eris Lifesciences (NSE:ERIS) Seems To Use Debt Quite Sensibly
Dec 07Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?
Nov 11Are Eris Lifesciences Limited (NSE:ERIS) Investors Paying Above The Intrinsic Value?
Jul 20Does Eris Lifesciences (NSE:ERIS) Have A Healthy Balance Sheet?
Nov 20These 4 Measures Indicate That Eris Lifesciences (NSE:ERIS) Is Using Debt Safely
Jun 20A Look At The Fair Value Of Eris Lifesciences Limited (NSE:ERIS)
Feb 24Is Now The Time To Put Eris Lifesciences (NSE:ERIS) On Your Watchlist?
Dec 28Here's Why I Think Eris Lifesciences (NSE:ERIS) Might Deserve Your Attention Today
Sep 23If You Like EPS Growth Then Check Out Eris Lifesciences (NSE:ERIS) Before It's Too Late
May 26Eris Lifesciences Limited (NSE:ERIS) Shares Could Be 34% Above Their Intrinsic Value Estimate
Apr 17Eris Lifesciences Limited's (NSE:ERIS) Stock Has Fared Decently: Is the Market Following Strong Financials?
Mar 12Does Eris Lifesciences (NSE:ERIS) Deserve A Spot On Your Watchlist?
Feb 25Why Eris Lifesciences Limited (NSE:ERIS) Is A Dividend Rockstar
Feb 12Eris Lifesciences Limited (NSE:ERIS) Analysts Are Pretty Bullish On The Stock After Recent Results
Jan 30Read This Before Buying Eris Lifesciences Limited (NSE:ERIS) Shares
Jan 17Our View On Eris Lifesciences' (NSE:ERIS) CEO Pay
Dec 30Is Eris Lifesciences Limited's (NSE:ERIS) Recent Performance Tethered To Its Attractive Financial Prospects?
Dec 10Eris Lifesciences (NSE:ERIS) Shareholders Booked A 25% Gain In The Last Year
Nov 23Is It Worth Buying Eris Lifesciences Limited (NSE:ERIS) For Its 1.1% Dividend Yield?
Oct 22How Does Eris Lifesciences' (NSE:ERIS) CEO Salary Compare to Peers?
Oct 01How Much Are Eris Lifesciences Limited (NSE:ERIS) Insiders Taking Off The Table?
Sep 14Investor Optimism Abounds Eris Lifesciences Limited (NSE:ERIS) But Growth Is Lacking
Aug 22Eris Lifesciences Limited (NSE:ERIS) Looks Interesting, And It's About To Pay A Dividend
Aug 08Should You Buy Eris Lifesciences Limited (NSE:ERIS) For Its Upcoming Dividend?
Aug 08決済の安定と成長
配当データの取得
安定した配当: 配当金の支払いは安定していますが、 ERISが配当金を支払っている期間は 10 年未満です。
増加する配当: ERISの配当金は増加していますが、同社は4年間しか配当金を支払っていません。
配当利回り対市場
| Eris Lifesciences 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (ERIS) | 0.7% |
| 市場下位25% (IN) | 0.3% |
| 市場トップ25% (IN) | 1.1% |
| 業界平均 (Pharmaceuticals) | 0.8% |
| 3年後のアナリスト予想 (ERIS) | 0.8% |
注目すべき配当: ERISの配当金 ( 0.72% ) はIndian市場の配当金支払者の下位 25% ( 0.27% ) よりも高くなっています。
高配当: ERISの配当金 ( 0.72% ) はIndian市場の配当金支払者の上位 25% ( 1.16% ) と比較すると低いです。
株主への利益配当
収益カバレッジ: ERISが配当金を報告していないため、配当金の持続可能性を計算できません。
株主配当金
キャッシュフローカバレッジ: ERISの 現金配当性向 ( 28% ) は比較的低く、配当金の支払いはキャッシュフローによって十分にカバーされています。